UBS lowered Oracle's price target from $285 to $245 due to concerns over rising AI infrastructure costs, credit market tightness, and Oracle's exposure to OpenAI. Despite these risks, UBS maintained a Buy rating, noting that some worries, like delays in Oracle's New Mexico data center project, may be overstated. The analysts see potential upside in Oracle's fiscal 2027 guidance and believe the stock's valuation already reflects material risks. Future gains depend on clearer returns from AI investments and Oracle's ability to expand its AI offerings amid competition.
Oracle's capital spending on AI infrastructure has surged, causing free cash flow to turn sharply negative and shifting funding reliance from internal cash to debt. This shift raises the cost of capital and pressures investment returns, evidenced by ...
This week, US economic data is light, shifting focus to geopolitics and corporate events. President Trump will host Chinese President Xi Jinping to discuss trade, tariffs, Taiwan, and AI, with potential announcements on Chinese purchases of US goods ...
Oracle Corporation faces near-term financial pressure due to a $664 billion backlog requiring significant capital expenditure, impacting cash flow, balance sheet, and net income. Despite this, the company is experiencing strong revenue growth and pro...
IBM has increased its dividend for 31 consecutive years, continuing a long-standing streak. However, the latest raise was minimal, only a penny per quarter, which does not keep pace with inflation rates around 3%. While IBM's dividend yield remains t...
Oracle announced a quarterly dividend of $0.50 per share payable on October 23, 2026, maintaining its payout from the previous quarter. This comes after a strong fiscal Q1 2027 report showing 30% revenue growth and a 62% surge in cloud revenue, drive...
